WATSON 3256 (Cyclobenzaprine 5 mg)
Pill imprint WATSON 3256 has been identified as Cyclobenzaprine hydrochloride 5 mg.
Cyclobenzaprine is used in the treatment of muscle spasm; sciatica; temporomandibular joint disorder; migraine; fibromyalgia (and more), and belongs to the drug class skeletal muscle relaxants. There is no proven risk in humans during pregnancy. Cyclobenzaprine 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 3256 (Cyclobenzaprine 5 mg)
- 5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Skeletal muscle relaxants
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
dibasic calcium phosphate
|NDC Code||Manufacturer / Repackager|
|16590-0544||Stat RX USA LLC (repackager)|
|21695-0036||Rebel Distributors Corp (repackager)|
|23490-7673||Palmetto State Pharmaceuticals Inc (repackager)|
|18837-0205||Innoviant Pharmacy Inc (repackager)|
|68071-0462||Nucare Pharmaceuticals Inc (repackager)|
|54868-5597||Physicians Total Care Inc (repackager)|
|33261-0377||Aidarex Pharmacuticals LLC (repackager)|
|68258-7013||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
Cyclobenzaprine hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...